Drug data last refreshed 12h ago · AI intelligence enriched 2w ago
Pralidoxime chloride is an injectable small-molecule antidote used to treat poisoning from organophosphate compounds (pesticides, nerve agents) and anticholinesterase drugs. It works by reactivating acetylcholinesterase, an enzyme inhibited by these toxins, restoring normal neuromuscular function. This is a critical emergency medicine product with narrow but high-acuity indications.
Product approaching loss of exclusivity with limited growth runway; team likely focused on supply chain optimization and cost management rather than market expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on pralidoxime offers deep expertise in emergency medicine, manufacturing excellence, and supply chain resilience for a critical public health product. This is a stable, lower-volume product ideal for professionals seeking operational mastery and regulatory/compliance focus rather than high-growth commercialization.
Worked on PRALIDOXIME CHLORIDE at Baxter International? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
480 open roles linked to this drug